V View Financial Report|Changchun High-tech: The State Food and Drug Administration has issued the approval document for recombinant human growth hormone injection

[V View Financial Report|Changchun High-tech: The State Food and Drug Administration has issued the approval document for recombinant human growth hormone injection] Changchun High-tech announced that the State Drug Administration has issued the company’s holding subsidiary Jinsai Pharmaceutical’s recombinant human growth hormone Approval documents for injection-related drugs, recombinant human growth hormone injection for this application (15IU/5mg/3ml/bottle, 30IU/10mg/3ml/bottle, 2IU/0.66mg/0.4ml/piece, 4.5IU/1.5mg /0.9ml/piece) is a new indication for idiopathic short stature (ISS). (Sino-Singapore Jingwei APP)